Functional exosome-mimic for delivery of siRNA to cancer:in vitro and in vivo evaluation

来源 :第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con | 被引量 : 0次 | 上传用户:loughtjiang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Exosomes,the smallest subgroup of extracellular vesicles,have been recognized as extracellular organelles that contain genetic and proteomic information for long distance intercellular communication.Exosome-based drug delivery is currently a subject of intensive research.
其他文献
  Nanomedicine is an emerging field combining nanotechnology with pharmaceutical and biomedical sciences,aiming to improve the efficacy of active drugs and im
会议
  Chemotherapy is the indispensable protocol in cancer therapy,which,however,suffers from the strong toxic side effect of the anti-cancer chemodrugs.Is it pos
会议
  Bimodal therapy(chemotherapy/nucleic acid therapy): Mesoporous silica nanoparticles(MSN)can load and deliver potentially synergistic anticancer agents such
会议
  Tumor cells are characterized as redox-heterogeneous intracellular microenvironment due to the simultaneous overproduction of reactive oxygen species(ROS)an
会议
  The precision nanomedicine significantly relies on the development of multifunctional agents to integrate cancer targeting,imaging and therapeutics.
会议
  Rheumatoid arthritis(RA)is a kind of severe chronic inflammatory disease which damages the joints of close 1%of human beings.Present clinical therapy applie
会议
  Liposome,a kind of nano drug delivery vehicle,has many advantages as targeted drug delivery,sustained release,improving API stability and reducing side effe
会议
  The prodrug nanomedicines(PNs)based on the molecular self-assembly of amphiphilic prodrugs were developed decades ago.They were also named as self-assembled
会议
  A synthetic carrier of siRNA with customizable size,pH-responsive degradability and optimized surface population of cell-targeting agent was constructed pre
会议
  Up to now,there are more than 70 kinds of protein drugs approved for marketing.More than 100 kinds of protein drugs have entered clinical trials.More than 4
会议